ZENIQUIN TABLETS 100MG

Land: Australien

Språk: engelska

Källa: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Köp det nu

Bipacksedel Bipacksedel (PIL)
20-06-2017
Produktens egenskaper Produktens egenskaper (SPC)
20-06-2017

Aktiva substanser:

MARBOFLOXACIN

Tillgänglig från:

ZOETIS AUSTRALIA PTY LTD

INN (International namn):

marbofloxacin(100mg/Tb)

Läkemedelsform:

ORAL TABLET

Sammansättning:

MARBOFLOXACIN ANTIBIOTIC Active 100.0 mg/Tb

Enheter i paketet:

50 Tablets

Klass:

VM - Veterinary Medicine

Tillverkad av:

ZOETIS AUSTRALIA

Terapeutisk grupp:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Terapiområde:

ANTIBIOTIC & RELATED

Terapeutiska indikationer:

BACILLUS SPP. | BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B | CORYNEBACTERIUM SPP. | ENTEROCOCCUS FAECALIS | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF THE SKIN | INFECTIONS OF THE URINARY TRACTS | KLEBSIELLA PNEUMONIAE | PASTEURELLA MULTOCIDA | PROTEUS MIRABILIS | PSEUDOMONAS AERUGINOSA | PSEUDOMONAS SPP. | SOFT TISSUE INFECTIONS | STAPHYLOCOCCUS AUREUS | STAPHYLOCOCCUS INTERMEDIUS | STREPTOCOCCUS SPP. | ABSCESSES | ANAL SACCULITIS | BACTERIAL CANKER | DEEP PYODERMAS | ESCHERICHIA COLI | FOWL CHOLERA | FUNGAL | GINGIVITIS | GRAM NEGATIVE BACTERIA | GRAM POSITIVE BACTERIA | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | INCLUDING SECONDARY INVADERS | KLEBSIELLA SPP. | NOT GROUP A | NOT GROUP B | POST-PARTURIENT INFECTIONS | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | PYODERMA | SEBORRHOEIC DERMATITIS | SEPTICAEMIA | STAPHYLOCOCCUS SPP. | YEAST

Produktsammanfattning:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [BACILLUS SPP., BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B, CORYNEBACTERIUM SPP., ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE SKIN, PASTEURELLA MULTOCIDA, SOFT TISSUE INFECTIONS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS INTERMEDIUS]; DOG: [BETA-HEMOLYTIC STREPTOCOCCUS (NOT A OR B, ENTEROCOCCUS FAECALIS, ESCHERICHIA COLI (E. COLI), INFECTIONS OF THE SKIN, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA PNEUMONIAE, PASTEURELLA MULTOCIDA, PROTEUS MIRABILIS, PSEUDOMONAS AERUGINOSA, PSEUDOMONAS SPP., SOFT TISSUE INFECTIONS, STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS INTERMEDIUS, STREPTOCOCCUS SPP.]; For the treatment in dogs of skin, soft tissue and urinary tract infections caused by organisms susceptible to marbofloxacin.

Bemyndigande status:

Registered

Tillstånd datum:

2022-07-01

Bipacksedel

                                LABEL IMAGE PROUDLY SUPPLIED BY
INFOPEST@DPI.QLD.GOV.AU
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                PRODUCT NAME: ZENIQUIN TABLETS
PAGE: 1 OF 5
This revision issued: September, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: 1800 814 883
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: 1800 814 883
Fax: (02) 9850 3399
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Blend of ingredients (see below). Active ingredient is antibacterial.
TRADE NAME:
ZENIQUIN TABLETS
PRODUCT USE:
Antibacterial preparation used in veterinary applications.
CREATION DATE:
JULY, 2006
THIS VERSION ISSUED:
SEPTEMBER, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Xn, Harmful. Hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R43, R62, R48/22. May cause sensitisation by skin contact. Possible
risk of impaired fertility.
Harmful: danger of serious damage to health by prolonged exposure if
swallowed.
SAFETY PHRASES:
S20, S22, S28, S36, S53. When using, do not eat or drink. Do not
breathe dust. After contact with
skin, wash immediately with plenty of soap and water. Wear suitable
protective clothing. Avoid exposure - obtain
special instructions before use.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Beige coloured film-coated tablets.
ODOUR:
Mild odour.
MAJOR HEALTH HAZARDS:
possible skin sensitiser, possible risk of impaired fertility. A
significant ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product
as it may cause sensiti
                                
                                Läs hela dokumentet